Case: Hatch-Waxman Patent Litigation Expenses Deductible as Ordinary, Necessary Business Expenses (Fed. Cir.) (IRC §263)

Expenses incurred by a generic drug manufacturer in defending Hatch-Waxman patent litigation are deductible as ordinary and necessary business expenses, the U.S. Court of Appeals for the Federal Circuit held, affirming the decision of the C
Read more...